BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 24599934)

  • 1. Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
    Sewell A; Brown B; Biktasova A; Mills GB; Lu Y; Tyson DR; Issaeva N; Yarbrough WG
    Clin Cancer Res; 2014 May; 20(9):2300-11. PubMed ID: 24599934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.
    Horn D; Freudlsperger C; Holzinger D; Kunzmann K; Plinkert P; Dyckhoff G; Hoffmann J; Freier K; Hess J
    Head Neck; 2017 Dec; 39(12):2397-2405. PubMed ID: 28945300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.
    Chiosea SI; Grandis JR; Lui VW; Diergaarde B; Maxwell JH; Ferris RL; Kim SW; Luvison A; Miller M; Nikiforova MN
    BMC Cancer; 2013 Dec; 13():602. PubMed ID: 24341335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Kondo S; Hirakawa H; Ikegami T; Uehara T; Agena S; Uezato J; Kinjyo H; Kise N; Yamashita Y; Tanaka K; Hasegawa N; Kiyuna A; Maeda H; Suzuki M; Gahana A
    BMC Cancer; 2021 Jan; 21(1):87. PubMed ID: 33482765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.
    Nichols AC; Palma DA; Chow W; Tan S; Rajakumar C; Rizzo G; Fung K; Kwan K; Wehrli B; Winquist E; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
    JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):617-22. PubMed ID: 23787421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma.
    Carper MB; Troutman S; Wagner BL; Byrd KM; Selitsky SR; Parag-Sharma K; Henry EC; Li W; Parker JS; Montgomery SA; Cleveland JL; Williams SE; Kissil JL; Hayes DN; Amelio AL
    Cell Rep; 2019 Nov; 29(6):1660-1674.e7. PubMed ID: 31693903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
    van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
    Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus genotype and oropharynx cancer survival in the United States of America.
    Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER
    Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
    Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
    Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
    Anayannis NV; Schlecht NF; Belbin TJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation.
    Beaty BT; Moon DH; Shen CJ; Amdur RJ; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman TG; Thorp B; Blumberg JM; Patel SN; Weissler MC; Yarbrough WG; Sheets NC; Parker JS; Neil Hayes D; Weck KE; Ramkissoon LA; Mendenhall WM; Dagan R; Tan X; Gupta GP; Chera BS
    J Natl Cancer Inst; 2020 Aug; 112(8):855-858. PubMed ID: 31747025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
    Peraldo-Neia C; Ostano P; Mello-Grand M; Guana F; Gregnanin I; Boschi D; Oliaro-Bosso S; Pippione AC; Carenzo A; De Cecco L; Cavalieri S; Micali A; Perrone F; Averono G; Bagnasacco P; Dosdegani R; Masini L; Krengli M; Aluffi-Valletti P; Valente G; Chiorino G
    Cell Oncol (Dordr); 2021 Apr; 44(2):357-372. PubMed ID: 33211282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
    Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
    Chakravarthy A; Henderson S; Thirdborough SM; Ottensmeier CH; Su X; Lechner M; Feber A; Thomas GJ; Fenton TR
    J Clin Oncol; 2016 Dec; 34(34):4132-4141. PubMed ID: 27863190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.
    Marquard FE; Jücker M
    Biochem Pharmacol; 2020 Feb; 172():113729. PubMed ID: 31785230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.